Zhang, Shao-Yan
Fu, Ji-You
Guo, Xiao-Yan
Wu, Ding-Zhong
Zhang, Tong
Li, Cui
Qiu, Lei
Shao, Chang-Rong
Xiao, He-Ping
Chu, Nai-Hui
Deng, Qun-Yi
Zhang, Xia
Yan, Xiao-Feng
Wang, Zhao-Long
Zhang, Zhi-Jie
Jiang, Xin
Zheng, Yue-Juan
Zheng, Pei-Yong
Zhang, Hui-Yong
Lu, Zhen-Hui
Funding for this research was provided by:
the Eleventh Five-Year Support Project of the Ministry of Science and Technology from Ministry of Public Health of China (2010ZX09101-107)
Article History
Received: 23 October 2019
Accepted: 8 April 2020
First Online: 7 May 2020
Ethics approval and consent to participate
: Prior to trial initiation, investigators obtained approval of ethical documents from the Institutional Review Board of Longhua Hospital, Shanghai University of TCM in China on December 16th 2010 (No: 2010LCSY014) and drug clinical trial for QBDT from China Food and Drug Administration (No: 2009 L00473). This trial is registered at ClinicalTrials.gov(NCT02313610).
: Not applicable.
: The authors declare that they have no competing interests.